Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Glucagon Receptor Antagonism on Ketogenesis in SGLT-2i Treated Subjects With T1D

NCT04545411 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT04545411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04545411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Glucagon Receptor Antagonism on Ketogenesis in SGLT-2i Treated Subjects With T1D
Lead sponsor
University of California, San Diego
Phase
Phase 1/2
Overall status
Completed
Start date
February 22, 2021
Completion date
October 31, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes